BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 18936691)

  • 1. The villous stromal constituents of complete hydatidiform mole differ histologically in very early pregnancy from the normally developing placenta.
    Kim KR; Park BH; Hong YO; Kwon HC; Robboy SJ
    Am J Surg Pathol; 2009 Feb; 33(2):176-85. PubMed ID: 18936691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and pathogenetic significance of increased stromal apoptosis and incomplete vasculogenesis in complete hydatidiform moles in very early pregnancy periods.
    Kim MJ; Kim KR; Ro JY; Lage JM; Lee HI
    Am J Surg Pathol; 2006 Mar; 30(3):362-9. PubMed ID: 16538057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete hydatidiform mole. Comparison of clinicopathologic features, current and past.
    Mosher R; Goldstein DP; Berkowitz R; Bernstein M; Genest DR
    J Reprod Med; 1998 Jan; 43(1):21-7. PubMed ID: 9475145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
    Hussein MR
    Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histopathological features of hydatidiform moles and placenta changes of nonmolar miscarriage in early stage of pregnancy].
    Dong Y; Zhang S; Wang ML; Guo H; Zhang Y; Wang Y; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):194-8. PubMed ID: 21503111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 expression in placentas with hydropic change and hydatidiform moles.
    Cheville JC; Robinson RA; Benda JA
    Mod Pathol; 1996 Apr; 9(4):392-6. PubMed ID: 8729978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic and immunohistochemical evaluation of blood vessels in complete and partial hydatidiform mole.
    Dickson-González SM; García de Barriola V; Barbella-Aponte RA; Figueira L; Cortés-Charry R; Naranjo de Gómez M
    J Reprod Med; 2006 Dec; 51(12):933-7. PubMed ID: 17253040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective pericyte recruitment of villous stromal vessels as the possible etiologic cause of hydropic change in complete hydatidiform mole.
    Kim KR; Sung CO; Kwon TJ; Lee J; Robboy SJ
    PLoS One; 2015; 10(4):e0122266. PubMed ID: 25849742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Ki-67 (MIB-1) in placentas with hydropic change and partial and complete hydatidiform mole.
    Cheville JC; Robinson R; Benda JA
    Pediatr Pathol Lab Med; 1996; 16(1):41-50. PubMed ID: 8963630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasculogenesis in complete and partial hydatidiform mole pregnancies studied with CD34 immunohistochemistry.
    Lisman BA; Boer K; Bleker OP; van Wely M; Exalto N
    Hum Reprod; 2005 Aug; 20(8):2334-9. PubMed ID: 15878926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal thrombotic vasculopathy in twin placentas with complete hydatidiform mole.
    Ernst LM; Chou D; Parry S
    Pediatr Dev Pathol; 2009; 12(1):63-7. PubMed ID: 18702565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the p53 gene in trophoblastic cells in hydatidiform moles and normal human placentas.
    Cheung AN; Srivastava G; Chung LP; Ngan HY; Man TK; Liu YT; Chen WZ; Collins RJ; Wong LC; Ma HK
    J Reprod Med; 1994 Mar; 39(3):223-7. PubMed ID: 8035377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abortions and moles.
    Benirschke K
    Monogr Pathol; 1981; (22):23-48. PubMed ID: 7024787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decidual immune cell infiltrate in hydatidiform mole.
    Hussein MR; Abd-Elwahed AR; Abodeif ES; Abdulwahed SR
    Cancer Invest; 2009 Jan; 27(1):60-6. PubMed ID: 19160109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.
    Sebire NJ; Fisher RA; Foskett M; Rees H; Seckl MJ; Newlands ES
    BJOG; 2003 Jan; 110(1):22-6. PubMed ID: 12504931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of leukemia inhibitory factor and insulin like growth factor-1 between normal pregnancies, partial hydatidiform moles and complete hydatidiform moles.
    Yucel Cicek OS; Hekimoglu ER; Turgal M; Atilla P; Cakar AN; Usubutun A; Beksac MS
    Placenta; 2018 Sep; 69():64-70. PubMed ID: 30213486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do AgNOR counts reflect cellular ploidy or cellular proliferation? A study of trophoblastic tissue.
    Suresh UR; Chawner L; Buckley CH; Fox H
    J Pathol; 1990 Mar; 160(3):213-5. PubMed ID: 2335802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of maspin in gestational trophoblastic disease.
    Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
    Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intact Chorionic Vesicle in Very Early Products of Conception Specimens: Clinicopathologic Features of 26 Cases That May Mimic Complete Hydatidiform Mole.
    Kayraklioglu N; Gasper C; Cho SJ; Lage J; Rabban JT
    Am J Surg Pathol; 2023 Mar; 47(3):397-408. PubMed ID: 36729386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic and clinicopathologic studies of partial moles.
    Ohama K; Ueda K; Okamoto E; Takenaka M; Fujiwara A
    Obstet Gynecol; 1986 Aug; 68(2):259-62. PubMed ID: 2426638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.